ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2026/10/08 | 3,755 | 3,757 | 3,702 | 3,745 | -4 | -0.1% | 331,400 |
| 2026/10/07 | 3,719 | 3,749 | 3,715 | 3,749 | +24 | +0.6% | 324,700 |
| 2026/10/06 | 3,728 | 3,742 | 3,713 | 3,725 | +18 | +0.5% | 375,500 |
| 2026/10/05 | 3,726 | 3,733 | 3,697 | 3,707 | +4 | +0.1% | 306,700 |
| 2026/10/02 | 3,735 | 3,735 | 3,693 | 3,703 | -46 | -1.2% | 353,100 |
| 2026/10/01 | 3,785 | 3,785 | 3,718 | 3,749 | -37 | -1% | 432,100 |
| 2026/09/30 | 3,810 | 3,811 | 3,735 | 3,786 | -11 | -0.3% | 762,800 |
| 2026/09/29 | 3,780 | 3,803 | 3,753 | 3,797 | -60 | -1.6% | 541,900 |
| 2026/09/28 | 3,878 | 3,885 | 3,857 | 3,857 | -21 | -0.5% | 557,500 |
| 2026/09/25 | 3,840 | 3,878 | 3,838 | 3,878 | +45 | +1.2% | 431,200 |
| 2026/09/24 | 3,840 | 3,871 | 3,821 | 3,833 | -15 | -0.4% | 435,100 |
| 2026/09/18 | 3,886 | 3,888 | 3,844 | 3,848 | -38 | -1% | 1,343,300 |
| 2026/09/17 | 3,812 | 3,886 | 3,808 | 3,886 | +84 | +2.2% | 800,200 |
| 2026/09/16 | 3,798 | 3,802 | 3,764 | 3,802 | +36 | +1% | 332,000 |
| 2026/09/15 | 3,792 | 3,803 | 3,758 | 3,766 | -23 | -0.6% | 511,900 |
| 2026/09/14 | 3,721 | 3,789 | 3,716 | 3,789 | +72 | +1.9% | 508,100 |
| 2026/09/11 | 3,663 | 3,728 | 3,663 | 3,717 | +6 | +0.2% | 544,400 |
| 2026/09/10 | 3,647 | 3,725 | 3,647 | 3,711 | +45 | +1.2% | 605,900 |
| 2026/09/09 | 3,660 | 3,676 | 3,642 | 3,666 | -18 | -0.5% | 1,065,100 |
| 2026/09/08 | 3,693 | 3,697 | 3,666 | 3,684 | -9 | -0.2% | 604,400 |
| 2026/09/07 | 3,715 | 3,724 | 3,692 | 3,693 | -21 | -0.6% | 682,000 |
| 2026/09/04 | 3,730 | 3,749 | 3,712 | 3,714 | -37 | -1% | 549,800 |
| 2026/09/03 | 3,775 | 3,782 | 3,751 | 3,751 | -29 | -0.8% | 489,500 |
| 2026/09/02 | 3,774 | 3,806 | 3,768 | 3,780 | -20 | -0.5% | 449,200 |
| 2026/09/01 | 3,780 | 3,817 | 3,777 | 3,800 | +18 | +0.5% | 396,700 |
| 2026/08/31 | 3,784 | 3,793 | 3,771 | 3,782 | -2 | -0.1% | 405,300 |
| 2026/08/28 | 3,818 | 3,824 | 3,784 | 3,784 | -45 | -1.2% | 362,500 |
| 2026/08/27 | 3,810 | 3,870 | 3,810 | 3,829 | +25 | +0.7% | 456,800 |
| 2026/08/26 | 3,780 | 3,823 | 3,780 | 3,804 | +21 | +0.6% | 416,400 |
| 2026/08/25 | 3,805 | 3,816 | 3,773 | 3,783 | +12 | +0.3% | 506,000 |
| 2026/08/24 | 3,770 | 3,802 | 3,762 | 3,771 | +4 | +0.1% | 332,700 |
| 2026/08/21 | 3,745 | 3,780 | 3,732 | 3,767 | +19 | +0.5% | 355,100 |
| 2026/08/20 | 3,740 | 3,761 | 3,724 | 3,748 | +27 | +0.7% | 512,900 |
| 2026/08/19 | 3,743 | 3,749 | 3,703 | 3,721 | -19 | -0.5% | 400,600 |
| 2026/08/18 | 3,745 | 3,759 | 3,706 | 3,740 | +20 | +0.5% | 572,600 |
| 2026/08/17 | 3,767 | 3,771 | 3,720 | 3,720 | -32 | -0.9% | 506,500 |
| 2026/08/14 | 3,750 | 3,772 | 3,741 | 3,752 | +9 | +0.2% | 347,900 |
| 2026/08/13 | 3,791 | 3,792 | 3,729 | 3,743 | -34 | -0.9% | 485,400 |
| 2026/08/12 | 3,788 | 3,790 | 3,755 | 3,777 | +20 | +0.5% | 361,800 |
| 2026/08/10 | 3,780 | 3,788 | 3,746 | 3,757 | -14 | -0.4% | 409,800 |
| 2026/08/07 | 3,770 | 3,796 | 3,737 | 3,771 | +8 | +0.2% | 487,500 |
| 2026/08/06 | 3,738 | 3,800 | 3,717 | 3,763 | +49 | +1.3% | 521,500 |
| 2026/08/05 | 3,754 | 3,770 | 3,702 | 3,714 | -53 | -1.4% | 382,400 |
| 2026/08/04 | 3,790 | 3,791 | 3,751 | 3,767 | -23 | -0.6% | 253,200 |
| 2026/08/03 | 3,800 | 3,809 | 3,730 | 3,790 | -27 | -0.7% | 477,800 |
| 2026/07/31 | 3,900 | 3,917 | 3,817 | 3,817 | -119 | -3% | 550,100 |
| 2026/07/30 | 4,044 | 4,045 | 3,904 | 3,936 | -109 | -2.7% | 356,300 |
| 2026/07/29 | 3,971 | 4,079 | 3,926 | 4,045 | +116 | +3% | 686,300 |
| 2026/07/28 | 3,950 | 3,976 | 3,906 | 3,929 | -12 | -0.3% | 521,600 |
| 2026/07/27 | 3,815 | 3,942 | 3,810 | 3,941 | +142 | +3.7% | 641,000 |
1～
50
件表示中 / 4041件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 377,500円 | +10.9% | -11.3% | 4.19% | 10.75倍 | 0.88倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| ロート | 269,250円 | +8.3% | -1.2% | 1.86% | 17.20倍 | 2.01倍 |
|
一般用医薬品の目薬で世界首位。「肌研」が急成長しスキンケアが柱に。アジアなど海外積極進出 |
| 参天薬 | 168,350円 | +6.6% | +4.3% | 2.49% | 13.52倍 | 1.82倍 |
|
緑内障、加齢黄斑変性、ドライアイ治療薬など眼科用医薬品首位。一般用目薬「サンテ」が有名 |
| 日本新薬 | 338,700円 | +17.1% | +5.9% | 3.66% | 7.53倍 | 0.78倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| ジーエヌアイ | 323,000円 | +76.3% | - | 0.00% | - | 5.26倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
市場注目の銘柄
チャート関連のコラム
